Annual Drug Patent Expirations for BEVESPI+AEROSPHERE
Bevespi Aerosphere is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has one hundred and thirty-two patent family members in thirty countries.
The generic ingredient in BEVESPI AEROSPHERE is formoterol fumarate; glycopyrrolate. One supplier is listed for this compound. Additional details are available on the formoterol fumarate; glycopyrrolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com